Free Trial

Mn Services Vermogensbeheer B.V. Has $11.73 Million Stock Holdings in Centene Corporation (NYSE:CNC)

Centene logo with Medical background

Mn Services Vermogensbeheer B.V. trimmed its position in shares of Centene Corporation (NYSE:CNC - Free Report) by 7.2% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 193,200 shares of the company's stock after selling 15,100 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in Centene were worth $11,729,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CNC. Ameriflex Group Inc. acquired a new position in Centene during the fourth quarter worth about $26,000. Pinney & Scofield Inc. acquired a new position in shares of Centene during the 4th quarter valued at about $25,000. Capital Advisors Ltd. LLC grew its holdings in shares of Centene by 75.3% in the fourth quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock valued at $25,000 after purchasing an additional 177 shares during the period. Hurley Capital LLC purchased a new position in Centene during the fourth quarter worth about $26,000. Finally, Rialto Wealth Management LLC acquired a new position in Centene in the 4th quarter valued at about $30,000. Hedge funds and other institutional investors own 93.63% of the company's stock.

Analyst Ratings Changes

CNC has been the topic of several analyst reports. Guggenheim reaffirmed a "neutral" rating on shares of Centene in a research report on Tuesday, April 29th. Robert W. Baird cut their price objective on Centene from $71.00 to $69.00 and set a "neutral" rating for the company in a research report on Tuesday, April 15th. Wall Street Zen lowered shares of Centene from a "strong-buy" rating to a "buy" rating in a research note on Monday, April 28th. Morgan Stanley initiated coverage on shares of Centene in a report on Monday, June 9th. They issued an "overweight" rating and a $70.00 price objective on the stock. Finally, Jefferies Financial Group dropped their price objective on Centene from $64.00 to $61.00 and set a "hold" rating for the company in a research note on Tuesday, April 29th. Seven equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $77.71.

View Our Latest Report on CNC

Centene Trading Up 0.4%

Shares of CNC stock traded up $0.23 on Tuesday, reaching $54.91. 4,359,794 shares of the stock were exchanged, compared to its average volume of 4,908,842. The stock has a 50 day moving average price of $59.13 and a 200 day moving average price of $59.88. The stock has a market cap of $27.32 billion, a PE ratio of 7.06, a P/E/G ratio of 0.65 and a beta of 0.45. Centene Corporation has a one year low of $53.99 and a one year high of $80.59. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.11 and a quick ratio of 1.11.

Centene (NYSE:CNC - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $2.90 EPS for the quarter, topping analysts' consensus estimates of $2.52 by $0.38. Centene had a net margin of 2.04% and a return on equity of 14.56%. The business had revenue of $46.62 billion for the quarter, compared to analyst estimates of $43.16 billion. During the same period last year, the business posted $2.26 earnings per share. The firm's quarterly revenue was up 15.4% on a year-over-year basis. Equities research analysts forecast that Centene Corporation will post 6.86 EPS for the current fiscal year.

About Centene

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Read More

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Should You Invest $1,000 in Centene Right Now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines